EPISODE · Mar 18, 2026 · 9 MIN
结肠镜质量评估的新指标：全量腺瘤检出率（ADR-A）
from 消化肝病前沿资讯
本期播客聚焦结肠镜检查质量评估的新指标“全量腺瘤检出率”（All-exam ADR），解析其相较传统筛查性ADR的优势：减少分类偏差、扩大样本提升稳定性，且预测术后复发风险效果相当。研究显示当前标杆为35%，未来或升至45%。探讨不同检查类型差异、锯齿状息肉检出率的意义及患者知情价值，并强调透明化质量数据对医患共同决策的重要性。00:06引入全量腺瘤检出率概念00:53全量ADR的操作优势解析01:45研究数据与风险预测表现02:49标准随技术进步或提升03:28实际应用中的挑战与差异04:19术后复发定义与时间窗口05:15锯齿状息肉检出率重要性05:58患者知情与医患讨论核心06:44数据局限与多样化验证需求07:41全量ADR的实用与推广前景08:56总结与展望质量改进
Embed this episode
Ready to play
结肠镜质量评估的新指标：全量腺瘤检出率（ADR-A）
0:00
9:05
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 消化肝病前沿资讯?
This episode is 9 minutes long.
When was this 消化肝病前沿资讯 episode published?
This episode was published on March 18, 2026.
Can I download this 消化肝病前沿资讯 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!